Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait

被引:6
作者
Cai, Yanwei [1 ]
Franceschini, Nora [2 ]
Surapaneni, Aditya [3 ,4 ]
Garrett, Melanie E. [5 ]
Tahir, Usman A. [6 ,7 ,8 ]
Hsu, Li [1 ]
Telen, Marilyn J. [5 ,9 ]
Yu, Bing [10 ]
Tang, Hua [11 ]
Li, Yun [12 ]
Liu, Simin [13 ,14 ,15 ]
Gerszten, Robert E. [6 ,7 ,8 ]
Coresh, Josef [3 ,4 ]
Manson, JoAnn E. [16 ]
Wojcik, Genevieve L. [3 ]
Kooperberg, Charles [2 ]
Auer, Paul L. [17 ]
Foster, Matthew W. [18 ]
Grams, Morgan E. [19 ]
Ashley-Koch, Allison E. [5 ]
Raffield, Laura M. [12 ]
Reiner, Alex P. [1 ,20 ,21 ]
机构
[1] Fred Hutchinson Canc Ctr, Div Publ Hlth Sci, Seattle, WA USA
[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[5] Duke Univ Med Ctr, Duke Mol Physiol Inst, Durham, NC USA
[6] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Boston, MA USA
[7] Broad Inst MIT, Cambridge, MA 02142 USA
[8] MIT, Cambridge, MA USA
[9] Duke Univ Med Ctr, Dept Med, Div Hematol, Durham, NC USA
[10] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA
[11] Stanford Univ Sch Med, Dept Genet, Stanford, CA USA
[12] Univ N Carolina, Dept Genet, Chapel Hill, NC USA
[13] Brown Univ, Ctr Global Cardiometab Hlth, Dept Epidemiol, Providence, RI USA
[14] Brown Univ, Ctr Global Cardiometab Hlth, Dept Med, Providence, RI USA
[15] Brown Univ, Ctr Global Cardiometab Hlth, Dept Surg, Providence, RI USA
[16] Brigham & Womens Hosp, Harvard Med Sch, Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[17] Med Coll Wisconsin, Inst Hlth & Equ & Canc Ctr, Div Biostat, Milwaukee, WI USA
[18] Duke Univ Med Ctr, Dept Med, Div Pulm Allergy & Crit Care, Durham, NC USA
[19] New York Univ Grossman Sch Med, Dept Med, Div Precis Med, New York, NY USA
[20] Univ Washington, Dept Epidemiol, Seattle, WA USA
[21] Univ ofWashington, Dept Epidemiol, 1959 NE Pacif St,Hlth Sci Bldg,F-262,262,Box 35723, Seattle, WA 98195 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2023年 / 18卷 / 11期
关键词
CKD; human genetics; KIDNEY-DISEASE; RISK; HEMOLYSIS;
D O I
10.2215/CJN.0000000000000257
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait. Methods We measured proteomics (N=1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait. Results In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait-protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait-associated proteins are known biomarkers of kidney function or injury (e.g., hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and alpha-hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait-associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58). Conclusions We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.
引用
收藏
页码:1416 / 1425
页数:10
相关论文
共 47 条
  • [1] Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
  • [2] [Anonymous], 2003, Am J Kidney Dis, V42, P1
  • [3] Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
    Assarsson, Erika
    Lundberg, Martin
    Holmquist, Goeran
    Bjoerkesten, Johan
    Thorsen, Stine Bucht
    Ekman, Daniel
    Eriksson, Anna
    Dickens, Emma Rennel
    Ohlsson, Sandra
    Edfeldt, Gabriella
    Andersson, Ann-Catrin
    Lindstedt, Patrik
    Stenvang, Jan
    Gullberg, Mats
    Fredriksson, Simon
    [J]. PLOS ONE, 2014, 9 (04):
  • [4] The nephropathy of sickle cell trait and sickle cell disease
    Ataga, Kenneth, I
    Saraf, Santosh L.
    Derebail, Vimal K.
    [J]. NATURE REVIEWS NEPHROLOGY, 2022, 18 (06) : 361 - 377
  • [5] Structure, Functions, and Physiological Roles of the Lipocalin α1-Microglobulin (A1M)
    Bergwik, Jesper
    Kristiansson, Amanda
    Allhorn, Maria
    Gram, Magnus
    Akerstrom, Bo
    [J]. FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [6] APOL1 Kidney Risk Variants and Proteomics
    Chen, Teresa K.
    Surapaneni, Aditya L.
    Arking, Dan E.
    Ballantyne, Christie M.
    Boerwinkle, Eric
    Chen, Jingsha
    Coresh, Josef
    Koettgen, Anna
    Susztak, Katalin
    Tin, Adrienne
    Yu, Bing
    Grams, Morgan E.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 684 - 692
  • [7] Biomarkers of Immune Activation and Incident Kidney Failure with Replacement Therapy: Findings From the African American Study of Kidney Disease and Hypertension
    Chen, Teresa K.
    Estrella, Michelle M.
    Appel, Lawrence J.
    Coresh, Josef
    Luo, Shengyuan
    Reiser, Jochen
    Obeid, Wassim
    Parikh, Chirag R.
    Grams, Morgan E.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (01) : 75 - +
  • [8] Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
    Cormican, Sarah
    Griffin, Matthew D.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives
    Cottas de Azevedo, Julia Teixeira
    Ribeiro Malmegrim, Kelen Cristina
    [J]. IMMUNOLOGY LETTERS, 2020, 224 : 1 - 11
  • [10] Monocyte chemoatractant protein-1: A potential biomarker of renal lesion and its relation with oxidative status in sickle cell disease
    de Jesus dos Santos, Talyta Ellen
    Goncalves, Romelia Pinheiro
    Barbosa, Maritza Cavalcante
    da Silva Junior, Geraldo Bezerra
    Daher, Elizabeth De Francesco
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (03) : 297 - 301